Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan.
Department of Prosthetic Dentistry, Ohu University School of Dentistry, Koriyama 963-8611, Japan.
Bone. 2021 Jul;148:115942. doi: 10.1016/j.bone.2021.115942. Epub 2021 Apr 6.
Dental implant treatment in patients prescribed medications is associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ) around the implants. However, there is no scientific information on how bisphosphonate and/or steroid therapies affect wound healing around implants after implant placement. The aim of this study was to histopathologically and immunopathologically investigate the effects of bisphosphonate and/or steroid therapy on the early stages of soft and hard tissue wound healing around implants in rat maxillae. Eight-week-old female Wistar rats were used. Alendronate (ALN) monotherapy, dexamethasone (DEX) monotherapy, and ALN/DEX combination therapy were started 4 weeks after tooth extraction of right maxillary first molars. Saline was used as a control (n = 14/group). Implant placement was carried out after grossly and manually confirming no open wounds at 16 weeks post-extraction. Euthanasia was performed at 18 weeks post-extraction. Microcomputed tomography, histological stains and immunostaining to detect blood vessels and macrophages were performed to quantitatively analyze wound healing around implants. ALN/DEX combination therapy significantly increased necrotic bone with more empty lacunae and polymorphonuclear cell infiltration with open wounds when compared with all other therapy groups. Necrotic bone was broadly distributed from the crestal bone to the lower area near the apex of the implants in the ALN/DEX group. Interestingly, both ALN/DEX combination therapy and DEX monotherapy significantly increased the number of CD68NG2 macrophages, whereas only ALN/DEX combination therapy, not DEX monotherapy, significantly shifted the M1/M2 ratio to M1 by significant increases in M1 macrophages and unchanged M2 macrophages in the connective tissue around implants. Within the limitations of this study, these findings may contribute to understanding the early stages of the histopathology and immunopathology of BRONJ-like lesions around dental implants. Continuous accumulation of M1 macrophages without alteration of M2 macrophages may be associated with developing BRONJ around implants.
在接受药物治疗的患者中进行牙种植体治疗与种植体周围的双膦酸盐相关颌骨坏死(BRONJ)有关。然而,目前尚无关于双膦酸盐和/或皮质类固醇治疗如何影响种植体放置后种植体周围的伤口愈合的科学信息。本研究的目的是通过组织病理学和免疫病理学研究双膦酸盐和/或皮质类固醇治疗对大鼠上颌骨种植体周围软组织和硬组织伤口愈合早期阶段的影响。使用 8 周龄雌性 Wistar 大鼠。在右上颌第一磨牙拔牙后 4 周开始进行阿仑膦酸钠(ALN)单药治疗、地塞米松(DEX)单药治疗和 ALN/DEX 联合治疗。生理盐水用作对照(n=14/组)。拔牙后 16 周,在大体和手动确认无开放性伤口后进行种植体放置。拔牙后 18 周进行安乐死。进行微计算机断层扫描、组织学染色和免疫染色以检测血管和巨噬细胞,以定量分析种植体周围的伤口愈合情况。与所有其他治疗组相比,ALN/DEX 联合治疗组的坏死骨中含有更多的空腔隙和多形核细胞浸润,且伴有开放性伤口,因此显著增加。在 ALN/DEX 组中,坏死骨广泛分布于种植体的嵴骨到靠近种植体根尖的下部区域。有趣的是,ALN/DEX 联合治疗和 DEX 单药治疗均显著增加了 CD68NG2 巨噬细胞的数量,而仅 ALN/DEX 联合治疗而非 DEX 单药治疗显著改变了 M1/M2 比值,导致种植体周围结缔组织中的 M1 巨噬细胞显著增加,而 M2 巨噬细胞不变。在本研究的限制范围内,这些发现可能有助于理解种植体周围 BRONJ 样病变的组织病理学和免疫病理学的早期阶段。M1 巨噬细胞的持续积累而 M2 巨噬细胞没有改变可能与种植体周围 BRONJ 的发生有关。